SCHEMBL7781746

SCHEMBL7781746

COc1ccc(/C(C#N)=N\OS(=O)(=O)c2c(C(C)C)cc(C(C)C)cc2C(C)C)cc1OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 1/20 0.39
▸ FABP3 P05413 1/20 0.37
▸ FABP4 P15090 1/20 0.37
▸ FABP5 Q01469 1/20 0.37
▸ ENPP3 O14638 2/20 0.37
▸ ENPP1 P22413 2/20 0.37
▸ PDE4B Q07343 10/20 0.36
▸ PDE4A P27815 9/20 0.36
▸ PDE4C Q08493 9/20 0.36
▸ PDE4D Q08499 9/20 0.36
▸ MAPT P10636 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ ELANE P08246 1/20 0.36
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7781748 1.00 HPGD (0.39) HPGDFABP3FABP4FABP5ENPP3
SCHEMBL7789380 0.80 PKM (0.43) HPGDPDE4BPDE4APDE4CPDE4D
SCHEMBL7789378 0.80 PKM (0.43) HPGDPDE4BPDE4APDE4CPDE4D
SCHEMBL7786399 0.79 HPGD (0.45) HPGDPDE4BPDE4APDE4CPDE4D
SCHEMBL7786268 0.79 ELANE (0.48) HPGDPDE4BPDE4APDE4CPDE4D
SCHEMBL7786974 0.79 ELANE (0.48) HPGDPDE4BPDE4APDE4CPDE4D
SCHEMBL7786962 0.78 NPC1 (0.47) HPGDPDE4BPDE4APDE4CPDE4D
SCHEMBL7786960 0.78 NPC1 (0.47) HPGDPDE4BPDE4APDE4CPDE4D
SCHEMBL7781706 0.77 PDE4A (0.47) PDE4BPDE4APDE4CPDE4DMAPT
SCHEMBL7781708 0.77 PDE4A (0.47) PDE4BPDE4APDE4CPDE4DMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010037037-A1 Oximesulfonic acid esters and the use thereof as latent sulfonic acids CIBA SPEICIALTY CHEMICALS CORP. 2001-11-01 — — US claimed
US-20010037037-A1 Oximesulfonic acid esters and the use thereof as latent sulfonic acids CIBA SPEICIALTY CHEMICALS CORP. 2001-11-01 — — US disclosed
US-6017675-A POLYMERIZATION CATALYST CIBA SPECIALTY CHEMIALS CORPORATION (US) 2000-01-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010037037-A1 Oximesulfonic acid esters and the use thereof as latent sulfonic acids QSOX1, HAO2, PAH HPGD 779/4885FABP3 3065/4885FABP4 4151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback